In contrast, CD14+ obtained from MM patients had a lower response to Glu, probably as a consequence of the in vivo exposure to the high-Glu microenvironment imposed by MM cells (Fig. 2B) [5]. The gene discussed is CD14; the disease is Miyoshi myopathy.